(R)-�-(4-Bromophenyl)alaninol, 97.0%, 1g

2-Chloro-5-fluoronicotinonitrile, 95.0%, 10g

trans-2-Dodecenal>90.0%(GC)25mL

3-Amino-4-chloro-N-(2-chloro-phenyl)-benzenesulfonamide, 100mg

4,5-Dibromo-6,7-dihydro-1H-indeno[5,4-b]furan-8(2H)-one, 97%, 1g

(2-Fluoro-4-(trifluoromethoxy)phenyl)boronic acid, 95.0%, 250mg

Glicole propilenico monoetil etere, min 99%, per sintesi, 5L, confezione in plastica.

4-((3-Chloro-2,4-difluorophenyl)amino)-7-methoxyquinazolin-6-ol, 97.0%, 250mg

(2R,3R,4R,5S)-Hexane-1,2,3,4,5,6-hexaol, 95.0%, 10g

p-Tolylacetic Acid>98.0%(GC)(T)25g

4-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)aniline, 95.0%, 1g

Methyl 3-(4-Pyridyl)-3-oxopropanoate, 95.0%, 25g

N,N-bis(2-methoxyethyl)methanesulfonamide, 95.0%, 250mg